Antimicrobial Resistance, an Update from the Ward: Increased Incidence of New Potential Pathogens and Site of Infection-Specific Antibacterial Resistances.

antimicrobial resistance bacterial infection community-acquired infections nosocomial infections

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
22 Sep 2020
Historique:
received: 27 08 2020
revised: 14 09 2020
accepted: 20 09 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 26 9 2020
Statut: epublish

Résumé

In order to monitor the spread of antimicrobial resistance, the European Union requires hospitals to be equipped with infection control centers. With this aim, we analyzed 1583 bacterial strains isolated from samples of different origin from patients with community-onset and nosocomial infections in a public tertiary University Hospital on the outskirts of Turin, Italy. Statistical analyses of the isolates (source, type) and their antimicrobial resistance (AMR) were performed. The survey revealed infections associated with bacterial species considered as not-commensal and not-pathogenic, hence potentially emerging as new threats for human health. Conversely to the general observation of nosocomial strains being more resistant to antibiotics compared to community-acquired strains, nosocomial strains isolated in this study were more resistant only to 1/42 tested antibiotics (tetracycline). By adopting an ecological approach, we observed that blood infections are associated with the broadest range of species compared to infections affecting other areas and we obtained clear indications on the antibiotics that should be preferred in the treatment of infections at specific body sites. Future investigations carried out on a larger geographical scale will clarify whether these indications are limited to the geographical region investigated over this study, or whether the same trends are visible at national or international level.

Identifiants

pubmed: 32971788
pii: antibiotics9090631
doi: 10.3390/antibiotics9090631
pmc: PMC7558927
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Università degli Studi di Torino
ID : MOGB_RILO_18_01
Organisme : Università degli Studi di Torino
ID : STEI_RILO_20_01

Références

PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
FEMS Microbiol Rev. 2017 May 1;41(3):252-275
pubmed: 28521338
Infect Dis Clin North Am. 2016 Jun;30(2):377-390
pubmed: 27208764
Lancet. 2005 Feb 12-18;365(9459):579-87
pubmed: 15708101
Ann Intern Med. 2002 Jun 4;136(11):834-44
pubmed: 12044132
J Clin Microbiol. 2018 Oct 25;56(11):
pubmed: 30135235
J Clin Microbiol. 1995 Sep;33(9):2508-10
pubmed: 7494062
J Clin Microbiol. 2019 Jan 30;57(2):
pubmed: 30333126
Antibiotics (Basel). 2020 Jun 08;9(6):
pubmed: 32521720
J Investig Med High Impact Case Rep. 2016 Sep 26;4(3):2324709616671148
pubmed: 27734018
Vet Microbiol. 2014 Jul 16;171(3-4):342-56
pubmed: 24629775
Ann N Y Acad Sci. 2019 Jan;1435(1):5-17
pubmed: 28574575
Antibiotics (Basel). 2020 May 19;9(5):
pubmed: 32438547
PLoS One. 2019 Dec 23;14(12):e0226676
pubmed: 31869354
Lancet. 2007 Feb 10;369(9560):482-90
pubmed: 17292768
Ann Intern Med. 2001 Aug 7;135(3):175-83
pubmed: 11487484
Int J Infect Dis. 2017 Dec;65:63-66
pubmed: 29030135
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30051804
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Heliyon. 2020 May 18;6(5):e03965
pubmed: 32490228
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Microbiol Spectr. 2016 Oct;4(5):
pubmed: 27780014

Auteurs

Irene Stefanini (I)

Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy.

Martina Boni (M)

Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy.

Paola Silvaplana (P)

Infectious Risk Prevention Unit, San Luigi Gonzaga University Hospital, Regione Gonzole 10, Orbassano, 10043 Turin, Italy.

Paola Lovera (P)

Infectious Risk Prevention Unit, San Luigi Gonzaga University Hospital, Regione Gonzole 10, Orbassano, 10043 Turin, Italy.

Stefania Pelassa (S)

Infectious Risk Prevention Unit, San Luigi Gonzaga University Hospital, Regione Gonzole 10, Orbassano, 10043 Turin, Italy.

Giuseppe De Renzi (G)

SCDO Laboratory of Clinical Pathology and Microbiology, San Luigi Gonzaga University Hospital, Regione Gonzole 10, Orbassano, 10043 Turin, Italy.

Barbara Mognetti (B)

Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy.

Classifications MeSH